A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive–compulsive disorder
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cognitive-behavioral group therapy (CBGT) and serotonin reuptake inhibitors have proven efficacy in reducing symptoms of obsessive-compulsive disorder (OCD). There is no consensus about which of these forms of treatment is more effective. This study was conducted to evaluate the efficacy of CBGT as compared to that of sertraline in reducing OCD symptoms. METHOD: Fifty-six outpatients with an OCD diagnosis, according to DSM-IV criteria, participated in the randomized clinical trial: 28 took 100 mg/day of sertraline and 28 underwent CBGT for 12 weeks. Efficacy of treatments was rated according to the reduction in scores on the Yale-Brown Obsessive Compulsive Scale (YBOCS) and the Clinical Global Impressions-Severity of Illness scale. The trial was performed in 4 successive periods from March 2002 to December 2003. RESULTS: Both treatments were effective, although patients treated with CBGT obtained a mean YBOCS reduction of symptoms of 44%, while those treated with sertraline obtained only a 28% reduction (p = .033). Cognitive-behavioral group therapy was also significantly more effective in reducing the intensity of compulsions (p = .030). Further, 8 patients (32%) treated with CBGT presented a complete remission of OCD symptoms (YBOCS score < or = 8) as compared to only 1 patient (4%) among those who received sertraline (p = .023). CONCLUSION: Cognitive-behavioral group therapy and sertraline have shown to be effective in reducing OCD symptoms. Nevertheless, the rate of symptom reduction, intensity reduction of compulsions, and percentage of patients who obtained full remission were significantly higher in patients treated with CBGT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One study found CBT superior to sertraline in reducing OCD symptoms, but the medication dosage was low (100 mg/day) and most of the differences between treatment effects were non-significant trends (Sousa et al., 2006).”
From An update on the efficacy of psychological treatments for obsessive-compulsive disorder in adults (2013) · cites this paper as Sousa et al., 2006
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 2×
“Depressive symptoms were rated with the BDI.(19) Anxiety symptoms were assessed with the Beck Anxiety Inventory (BAI).”
MethodAn inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · cited 1×
“Anxiety symptoms were assessed with the Beck Anxiety Inventory (BAI).(24) Both scales were translated and validated to Portuguese.”
Method(1976) · Medical Entomology and Zoology · Cited by 8,899
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712 · cited 2×
“The intensity of obsessive-compulsive symptoms was measured with the YBOCS.(18) Global clinical impression was assessed with the Clinical Global Impressions-Severity of Illness (CGI-S) scale.”
MethodThe mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
Fleck, M. P., Louzada, S., Xavier, M., Chachamovich, E., Vieira, G., Santos, L., & Pinzon, V. (2000) · Revista de Saúde Pública · doi:10.1590/s0034-89102000000200012 · Cited by 1,933
The Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
Karno, M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360042006 · Cited by 1,351 · cited 1×
“population.(1) The disorder is usually a chronic condition that often begins before adulthood and generally continues throughout life.”
BackgroundA multidimensional model of obsessive-compulsive disorder
Mataix-Cols, D., do Rosario-Campos, M. C., & Leckman, J. F. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.228 · Cited by 1,074 · cited 6×
“The situation becomes even more complex due to a probable heterogeneity of OCD.(4,5) Some studies were conducted with adult patients by comparing exposure and response prevention (ERP) therapy to clomipramine and fluvoxamine.”
BackgroundInfluentialAmorim, P. (2000) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462000000300003 · Cited by 1,070
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
The Epidemiology and Clinical Features of Obsessive Compulsive Disorder
Rasmussen, S. A., & Eisen, J. L. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30205-3 · Cited by 867 · cited 1×
“The disorder is usually a chronic condition that often begins before adulthood and generally continues throughout life.(2) Serotonin reuptake inhibitor (SRI)–antidepressants and cognitive-behavioral therapy (CBT) are first-choice treatments for OCD.”
BackgroundClomipramine and Exposure for Obsessive-Compulsive Rituals: 1
Marks, I. M., Stern, R. S., Mawson, D., Cobb, J., & McDonald, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.1.1 · Cited by 448 · cited 4×
“Our study showed superiority for CBGT even though this therapy was not applied intensively, as ERP was when Marks et al.6 and Foa et al.8 performed their studies.”
MethodResultInfluentialFALS-STEWART, W., MARKS, A. P., & SCHAFER, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199303000-00007 · Cited by 279 · cited 1×
“Exposure and response prevention behavioral group therapy has a similar efficacy to ERP individual therapy in reducing obsessive-compulsive symptoms.(12) Cognitivebehavioral group therapy (CBGT) has equally shown to be effective in the treatment of patients with OCD.”
MethodBehavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis
Kobak, K. A., Greist, J. H., Jefferson, J. W., Katzelnick, D. J., & Henk, H. J. (1998) · Psychopharmacology · doi:10.1007/s002130050558 · Cited by 276 · cited 4×
“The average rate of dropout in OCD clinical trials is 24% with sertraline and 17% with ERP.35 A possible explanation for this higher degree of compliance may be the fact that the patients’ motivation for taking any of the 2 types of treatment was taken into consideration when assessing patients prior to the trial.”
BackgroundInfluentialClomipramine, self-exposure and therapist-aided exposure for obsessive–compulsive rituals
Marks, I. M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., & Kasvikis, Y. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.152.4.522 · Cited by 255 · cited 1×
“The superiority of CBGT over sertraline was considered in relation to compulsion improvement, an observation previously reported by other authors.(6,7,28) Exposure and response prevention therapy uses response prevention as a crucial treatment strategy, so that patients are directly stimulated to avoid their compulsio…”
ResultVAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199808000-00007 · Cited by 250 · cited 4×
“These data are in agreement with the study of Van Balkom et al.(10) regarding the BDI score as well as the study of Cordioli et al.”
BackgroundResultInfluentialNinan, P. T., Koran, L. M., Kiev, A., Davidson, J. R. T., Rasmussen, S. A., Zajecka, J. M., Robinson, D. G., Crits-Christoph, P., Mandel, F. S., & Austin, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0103 · Cited by 245 · cited 1×
“However, it is possible that, with a higher dose, some patients may have a different outcome.(40) The inclusion of patients who had undergone previous treatment with a SRI could be a limitation of this study, as a lack of response to prior adequate trials of an appropriate SSRI would lead one to predict less likelihoo…”
BackgroundGreist, J. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160039008 · Cited by 243 · cited 3×
“Usually, OCD pharmacologic clinical trials do not enable a mean symptom reduction to subclinical levels.(15,27) Cognitive-behavioral group therapy sessions were held weekly, lasting for 2 hours, and this treatment showed better results than sertraline after several analyses.”
BackgroundResultA Controlled Study of Fluvoxamine and Exposure in Obsessive-Compulsive Disorder
COTTRAUX, J., MOLLARD, E., BOUVARD, M., MARKS, I., SLUYS, M., NURY, A. M., DOUGE, R., & CIALDELLA, P. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199001000-00002 · Cited by 203 · cited 2×
“But Cottraux et al.(9) and Van Balkom et al.”
BackgroundCognitive-behavioral group therapy in obsessive–compulsive disorder: a randomized clinical trial
Volpato Cordioli, A., Heldt, E., Braga Bochi, D., Margis, R., Basso de Sousa, M., Fonseca Tonello, J., Gus Manfro, G., & Kapczinski, F. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000070785 · Cited by 158 · cited 10×
“As to symptom reduction percentage, results obtained were similar to those seen in previous studies with CBGT and sertraline.(13,15) The superiority of CBGT over sertraline was considered in relation to compulsion improvement, an observation previously reported by other authors.”
MethodResultInfluentialSelf-citationTreatment strategies for chronic and refractory obsessive-compulsive disorder.
Rasmussen, S. A., & Eisen, J. L. (1997) · PubMed · Cited by 138
Chouinard, G., Goodman, W. K., Greist, J. H., Jenike, M. A., Rasmussen, S., White, K., Hackett, E., Gaffney, M., & Bick, P. A. (1990) · PubMed · Cited by 136
Greist, J. H., Jefferson, J. W., Kobak, K. A., Chouinard, G., DuBoff, E., Halaris, A., Kim, S. W., Koran, L., Liebowtiz, M. R., Lydiard, B., et al. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199506000-00001 · Cited by 133
Hollander, E., Koran, L. M., Goodman, W. K., Greist, J. H., Ninan, P. T., Yang, H., Li, D., & Barbato, L. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0604 · Cited by 103 · cited 1×
“A previous pharmacologic study, which used similar criteria, reported a complete remission rate in 18% of patients with OCD who took fluvoxamine.(29) The latter finding is a relevant one, as a complete symptom remission seems to be related to a lower probability of relapse into OCD(30) and other psychiatric disorders.”
ResultNakatani, E., Nakagawa, A., Nakao, T., Yoshizato, C., Nabeyama, M., Kudo, A., Isomura, K., Kato, N., Yoshioka, K., & Kawamoto, M. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000086317 · Cited by 102
Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
O'Sullivan, G. H., Noshirvani, H., Marks, I. M., Monteiro, W., & Lelliott, P. T. (1991) · PubMed · Cited by 99
Achieving remission and managing relapse in depression.
Thase, M. E. (2003) · PubMed · Cited by 91
Patients with obsessive-compulsive disorder and hoarding symptoms: A distinctive clinical subtype?
Fontenelle, L. F., Mendlowicz, M. V., Soares, I. D., & Versiani, M. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2004.03.005 · Cited by 88
Cognitive‐behavioral group therapy for obsessive–compulsive disorder: a 1‐year follow‐up
Braga, D. T., Cordioli, A. V., Niederauer, K., & Manfro, G. G. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00559.x · Cited by 71
Self-citationAbel, J. L. (1993) · Behaviour Research and Therapy · doi:10.1016/0005-7967(93)90127-g · Cited by 51 · cited 1×
“The superiority of CBGT over sertraline was considered in relation to compulsion improvement, an observation previously reported by other authors.(6,7,28) Exposure and response prevention therapy uses response prevention as a crucial treatment strategy, so that patients are directly stimulated to avoid their compulsio…”
ResultKipper, L., Blaya, C., Teruchkin, B., Heldt, E., Isolan, L., Mezzomo, K. M., Bond, M., & Manfro, G. G. (2003) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000106001.84359.0f · Cited by 47
Self-citationBeyond refractory obsessions and anxiety states: toward remission.
Hollander, E., & Zohar, J. (2004) · PubMed · Cited by 33
Asbahr, F. R., Ramos, R. T., Costa, A. N., & Sassi, R. B. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00455.x · Cited by 25
Paroxetine Treatment of Generalized Anxiety Disorder
Sheehan, D. V., Mao, C. G., Mba, Mao, A. C. G., & PharmD (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.7061 · Cited by 18 · cited 1×
“The latter finding is a relevant one, as a complete symptom remission seems to be related to a lower probability of relapse into OCD(30) and other psychiatric disorders.(31,32) According to some authors, there is a tendency to consider complete symptom remission as a goal while treating obsessive-compulsive symptoms a…”
Background
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“CBT is equivalent or superior to pharmacotherapy [71,658-660].”
BackgroundBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
“In a comparison of CBT and sertraline, CBT was more effective (Sousa et al. 2006).”
Response rates for CBT for anxiety disorders: need for standardized criteria
Loerinc, A. G., Meuret, A. E., Twohig, M. P., Rosenfield, D., Bluett, E. J., & Craske, M. G. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.08.004 · Cited by 592
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013) · World Psychiatry · doi:10.1002/wps.20038 · Cited by 540
“Sousa et al (87) OCD CBT (n525) SSRI (n525) 2 2 1 2 Brazil”
Skapinakis, P., Caldwell, D. M., Hollingworth, W., Bryden, P., Fineberg, N. A., Salkovskis, P., Welton, N. J., Baxter, H., Kessler, D., Churchill, R., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30069-4 · Cited by 407
“26,71,74,75 Taking all of this evidence into account, our analysis does not support the view that the three types of psychotherapy have diff erent eff ects in obsessive-compulsive disorder.”
Metadata
- Authors
- Sousa, M. B., Isolan, L. R., Oliveira, R. R., Manfro, G. G., & Cordioli, A. V.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-07-15
- Volume
- 67
- Issue
- 07
- Pages
- 1133-1139
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2082328558
- Cited by
- 110
- References
- 34
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 9 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 11
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- obsessive-compulsive disorder, group cognitive behavioral therapy, sertraline, serotonin reuptake inhibitors, treatment efficacy comparison, compulsive behavior, symptom remission, Yale-Brown Obsessive Compulsive Scale
- MeSH terms
- Adult, Ambulatory Care, Female, Humans, Male, Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales, Psychotherapy, Group, Quality of Life, Severity of Illness Index, Cognitive Behavioral Therapy, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.